|
|
 Previous Article | Table of Contents | Next Article 
EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
R. Willemze,
H. Kerl,
W. Sterry,
E. Berti,
L. Cerroni,
S. Chimenti,
J.L. Diaz-Peréz,
M.L. Geerts,
M. Goos,
R. Knobler,
E. Ralfkiaer,
M. Santucci,
N. Smith,
J. Wechsler,
W.A. van Vloten, and
C.J.L.M. Meijer
From the Departments of Dermatology and Pathology, Free University Hospital, Amsterdam, The Netherlands; the Department of Dermatology, University of Graz, Austria; the Department of Dermatology, Charité, Humboldt University, Berlin, Germany; the Department of Dermatology, University of Milan, Italy; the Department of Dermatology, University of L'Aquila, Italy; the Department of Dermatology, Cruces Hospital, Bilbao, Spain; the Department of Dermatology, University of Gent, Belgium; the Department of Dermatology, University of Essen, Germany; the Department of Dermatology, University of Vienna, Austria; the Department of Pathology, Herlev Hospital, University of Copenhagen, Denmark; the Department of Pathology, University of Florence, Italy; the Department of Dermatology, St John's Hospital, London, UK; the Department of Pathology, Hospital Henri Mondor, Paris, France; the Department of Dermatology, University of Utrecht, The Netherlands.
Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas that show considerable variation in histology, phenotype, and prognosis. Recently, the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group has reached consensus on a new classification for this group of diseases. The EORTC classification for primary cutaneous lymphomas is based on a combination of clinical, histologic, and immunophenotypic criteria, and thus contains well-defined disease entities rather than histologic subgroups. In addition, this new classification contains a number of provisional entities, which may display characteristic histologic features, but are not yet well defined clinically. These provisional entities account for less than 5% of all primary cutaneous lymphomas. In this report the basic principles of this new classification, as well as the characteristic features of the different disease entities, are described. In addition, survival data of 626 patients with primary cutaneous lymphomas derived from the registry of the Dutch Cutaneous Lymphoma Working Group, illustrating the clinical validity of this new classification, are presented.
Blood, Vol. 90 No. 1 (July 1), 1997:
pp. 354-371
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Garcia-Herrera, L. Colomo, M. Camos, J. Carreras, O. Balague, A. Martinez, A. Lopez-Guillermo, T. Estrach, and E. Campo
Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome
J. Clin. Oncol.,
July 10, 2008;
26(20):
3364 - 3371.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Quereux, S. Marques, J.-M. Nguyen, C. Bedane, M. D'incan, O. Dereure, E. Puzenat, A. Claudy, L. Martin, P. Joly, et al.
Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Sezary Syndrome
Arch Dermatol,
June 1, 2008;
144(6):
727 - 733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Sterry and L. Heinzerling
Clinical Research in Cutaneous T-Cell Lymphoma Moving Forward
Arch Dermatol,
June 1, 2008;
144(6):
786 - 787.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Willemze, P. M. Jansen, L. Cerroni, E. Berti, M. Santucci, C. Assaf, M. R. Canninga-van Dijk, A. Carlotti, M.-L. Geerts, S. Hahtola, et al.
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases
Blood,
January 15, 2008;
111(2):
838 - 845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Senff, J. J. Hoefnagel, K. J. Neelis, M. H. Vermeer, E. M. Noordijk, R. Willemze, and for the Dutch Cutaneous Lymphoma Group
Results of Radiotherapy in 153 Primary Cutaneous B-Cell Lymphomas Classified According to the WHO-EORTC Classification
Arch Dermatol,
December 1, 2007;
143(12):
1520 - 1526.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. L. Zinzani, G. Musuraca, M. Tani, V. Stefoni, E. Marchi, M. Fina, C. Pellegrini, L. Alinari, E. Derenzini, A. de Vivo, et al.
Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
J. Clin. Oncol.,
September 20, 2007;
25(27):
4293 - 4297.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Grange, M. Beylot-Barry, P. Courville, E. Maubec, M. Bagot, B. Vergier, P. Souteyrand, L. Machet, S. Dalac, E. Esteve, et al.
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Clinicopathologic Features and Prognostic Analysis in 60 Cases
Arch Dermatol,
September 1, 2007;
143(9):
1144 - 1150.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Marie-Cardine, D. Huet, N. Ortonne, N. Remtoula, S. L. Gouvello, M. Bagot, and A. Bensussan
Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome
Blood,
June 1, 2007;
109(11):
5064 - 5065.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Martusewicz-Boros, E. Wiatr, E. Radzikowska, K. Roszkowski-Sliz, and R. Langfort
Pulmonary Intravascular Large B-Cell Lymphoma As a Cause of Severe Hypoxemia
J. Clin. Oncol.,
May 20, 2007;
25(15):
2137 - 2139.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Senff, J. J. Hoefnagel, P. M. Jansen, M. H. Vermeer, J. van Baarlen, W. A. Blokx, M. R. Canninga-van Dijk, M.-L. Geerts, K. M. Hebeda, P. M. Kluin, et al.
Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO-EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers
J. Clin. Oncol.,
April 20, 2007;
25(12):
1581 - 1587.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. V. Cabrera, M. Amano, J. Mitoma, J. Chan, J. Said, M. Fukuda, and L. G. Baum
Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death
Blood,
October 1, 2006;
108(7):
2399 - 2406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Nebozhyn, A. Loboda, L. Kari, A. H. Rook, E. C. Vonderheid, S. Lessin, C. Berger, R. Edelson, C. Nichols, M. Yousef, et al.
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy
Blood,
April 15, 2006;
107(8):
3189 - 3196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. L. Zinzani, P. Quaglino, N. Pimpinelli, E. Berti, G. Baliva, S. Rupoli, M. Martelli, M. Alaibac, G. Borroni, S. Chimenti, et al.
Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas
J. Clin. Oncol.,
March 20, 2006;
24(9):
1376 - 1382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Dijkman, C. P. Tensen, E. S. Jordanova, J. Knijnenburg, J. J. Hoefnagel, A. A. Mulder, C. Rosenberg, A. K. Raap, R. Willemze, K. Szuhai, et al.
Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Primary Cutaneous Large B-Cell Lymphoma
J. Clin. Oncol.,
January 10, 2006;
24(2):
296 - 305.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Huet, M. Bagot, D. Loyaux, J. Capdevielle, L. Conraux, P. Ferrara, A. Bensussan, and A. Marie-Cardine
SC5 mAb Represents a Unique Tool for the Detection of Extracellular Vimentin as a Specific Marker of Sezary Cells
J. Immunol.,
January 1, 2006;
176(1):
652 - 659.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kodama, C. Massone, A. Chott, D. Metze, H. Kerl, and L. Cerroni
Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients
Blood,
October 1, 2005;
106(7):
2491 - 2497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Juarez, S. N. Isenhath, N. L. Polissar, D. E. Sabath, B. Wood, D. Hanke, C. L. Haycox, G. S. Wood, and J. E. Olerud
Analysis of T-Cell Receptor Gene Rearrangement for Predicting Clinical Outcome in Patients With Cutaneous T-Cell Lymphoma: A Comparison of Southern Blot and Polymerase Chain Reaction Methods
Arch Dermatol,
September 1, 2005;
141(9):
1107 - 1113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Hoefnagel, M. H. Vermeer, P. M. Jansen, F. Heule, P. C. van Voorst Vader, C. J. G. Sanders, M. J. P. Gerritsen, M. L. Geerts, C. J. L. M. Meijer, E. M. Noordijk, et al.
Primary Cutaneous Marginal Zone B-Cell Lymphoma: Clinical and Therapeutic Features in 50 Cases
Arch Dermatol,
September 1, 2005;
141(9):
1139 - 1145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. van Doorn, W. H. Zoutman, R. Dijkman, R. X. de Menezes, S. Commandeur, A. A. Mulder, P. A. van der Velden, M. H. Vermeer, R. Willemze, P. S. Yan, et al.
Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73
J. Clin. Oncol.,
June 10, 2005;
23(17):
3886 - 3896.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Smith, G. L. Smith, D. L. Cooper, and L. D. Wilson
The Cutaneous B-Cell Lymphoma Prognostic Index: A Novel Prognostic Index Derived From a Population-Based Registry
J. Clin. Oncol.,
May 20, 2005;
23(15):
3390 - 3395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Kadin
Latest lymphoma classification is skin deep
Blood,
May 15, 2005;
105(10):
3759 - 3759.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Willemze, E. S. Jaffe, G. Burg, L. Cerroni, E. Berti, S. H. Swerdlow, E. Ralfkiaer, S. Chimenti, J. L. Diaz-Perez, L. M. Duncan, et al.
WHO-EORTC classification for cutaneous lymphomas
Blood,
May 15, 2005;
105(10):
3768 - 3785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Hoefnagel, R. Dijkman, K. Basso, P. M. Jansen, C. Hallermann, R. Willemze, C. P. Tensen, and M. H. Vermeer
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
Blood,
May 1, 2005;
105(9):
3671 - 3678.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Querfeld, S. T. Rosen, T. M. Kuzel, K. A. Kirby, H. H. Roenigk Jr, B. M. Prinz, and J. Guitart
Long-term Follow-up of Patients With Early-Stage Cutaneous T-Cell Lymphoma Who Achieved Complete Remission With Psoralen Plus UV-A Monotherapy
Arch Dermatol,
March 1, 2005;
141(3):
305 - 311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Franck, A. Carlotti, I. Gorin, M. Buffet, C. Mateus, N. Dupin, and for the French Study Group on Cutaneous Lymphomas
Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma and Neutrophilic Dermatosis
Arch Dermatol,
March 1, 2005;
141(3):
353 - 356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S M Winhoven, S Murugesan, and I H Coulson
Solitary CD30+ anaplastic large cell lymphoma of the eyelid showing regression
Br. J. Ophthalmol.,
March 1, 2005;
89(3):
385 - 385.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Assaf, M. Hummel, M. Steinhoff, C. C. Geilen, H. Orawa, H. Stein, and C. E. Orfanos
Early TCR-{beta} and TCR-{gamma} PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications
Blood,
January 15, 2005;
105(2):
503 - 510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Assaf, M Hummel, M Zemlin, M Steinhoff, C C Geilen, H Stein, and C E Orfanos
Transition of Sezary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis
J. Clin. Pathol.,
December 1, 2004;
57(12):
1325 - 1328.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Dummer, J. C. Hassel, F. Fellenberg, S. Eichmuller, T. Maier, P. Slos, B. Acres, P. Bleuzen, V. Bataille, P. Squiban, et al.
Adenovirus-mediated intralesional interferon-{gamma} gene transfer induces tumor regressions in cutaneous lymphomas
Blood,
September 15, 2004;
104(6):
1631 - 1638.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Tancrede-Bohin, M. A. Ionescu, P. de La Salmoniere, A. Dupuy, J. Rivet, M. Rybojad, L. Dubertret, H. Bachelez, C. Lebbe, and P. Morel
Prognostic Value of Blood Eosinophilia in Primary Cutaneous T-Cell Lymphomas
Arch Dermatol,
September 1, 2004;
140(9):
1057 - 1061.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. van Doorn, R. Dijkman, M. H. Vermeer, J. J. Out-Luiting, E. M. H. van der Raaij-Helmer, R. Willemze, and C. P. Tensen
Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sezary Syndrome Identified by Gene Expression Analysis
Cancer Res.,
August 15, 2004;
64(16):
5578 - 5586.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Bekkenk, P. M. Jansen, C. J. L. M. Meijer, and R. Willemze
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature
Ann. Onc.,
July 1, 2004;
15(7):
1097 - 1108.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Rhinophymalike Swelling in an 86-Year-Old Woman--Diagnosis
Arch Dermatol,
June 1, 2004;
140(6):
751 - 751.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Grange, T. Petrella, M. Beylot-Barry, P. Joly, M. D'Incan, M. Delaunay, L. Machet, M.-F. Avril, S. Dalac, P. Bernard, et al.
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
Blood,
May 15, 2004;
103(10):
3662 - 3668.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Girardi, P. W. Heald, and L. D. Wilson
The Pathogenesis of Mycosis Fungoides
N. Engl. J. Med.,
May 6, 2004;
350(19):
1978 - 1988.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Lymphomatoid Papulosis: Reappraisal of Clinicopathologic Presentation and Classification Into Subtypes A, B, and C
Arch Dermatol,
April 1, 2004;
140(4):
441 - 447.
|
|
|
|
|
|
|
CD30+ Cutaneous Lymphoma in Association With Atopic Eczema
Arch Dermatol,
April 1, 2004;
140(4):
449 - 454.
|
|
|
|
|
|
|
Widespread Recurrent Lichenoid Papular Eruption--Diagnosis
Arch Dermatol,
April 1, 2004;
140(4):
479 - 484.
|
|
|
|
|
|
|
T. Nijsten, C. Curiel-Lewandrowski, and M. E. Kadin
Lymphomatoid Papulosis in Children: A Retrospective Cohort Study of 35 Cases
Arch Dermatol,
March 1, 2004;
140(3):
306 - 312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. D. Smith, E. J. Glusac, J. M. McNiff, G. L. Smith, P. W. Heald, D. L. Cooper, and L. D. Wilson
Primary Cutaneous B-Cell Lymphoma Treated With Radiotherapy: A Comparison of the European Organization for Research and Treatment of Cancer and the WHO Classification Systems
J. Clin. Oncol.,
February 15, 2004;
22(4):
634 - 639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. M. Raaphorst, M. Vermeer, E. Fieret, T. Blokzijl, D. Dukers, R. G.A.B. Sewalt, A. P. Otte, R. Willemze, and C. J.L.M. Meijer
Site-Specific Expression of Polycomb-Group Genes Encoding the HPC-HPH/PRC1 Complex in Clinically Defined Primary Nodal and Cutaneous Large B-Cell Lymphomas
Am. J. Pathol.,
February 1, 2 | |
